Suspected Lung Cancer Clinical Trial
Official title:
Implementation of Smoking Cessation Support During Lung Cancer Workup: a Pragmatic, Cluster-randomised Controlled Trial and an Interview-based Study of Patients' and Healthcare Professionals' Experiences
Verified date | June 2024 |
Source | Vejle Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the present project is to implement smoking cessation support in hospital-based lung cancer workup. The effect on 1) patients' smoking cessation attempts, motivation, quality of life and psychosocial consequences of lung cancer workup as well as 2) hospitals' number of referrals to municipality-based smoking cessation programmes will be evaluated in a pragmatic, cluster-randomised controlled setup, where participating hospitals will be assigned to the intervention arm (implementation of smoking cessation support) or the control arm (usual practice). Patients' and healthcare professionals' experiences with and barriers towards smoking cessation support will be explored in an interview-based, qualitative study.
Status | Active, not recruiting |
Enrollment | 295 |
Est. completion date | June 30, 2025 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Referred to lung cancer workup at participating hospital - Able to speak and understand Danish Exclusion Criteria: - Unable to complete electronic questionnaires |
Country | Name | City | State |
---|---|---|---|
Denmark | Vejle Hospital | Vejle |
Lead Sponsor | Collaborator |
---|---|
Vejle Hospital | Aalborg University Hospital, Aarhus University Hospital, Bispebjerg Hospital, Hospital of Southern Jutland, Naestved Hospital, Odense University Hospital, University Hospital, Gentofte, Copenhagen, Zealand University Hospital |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of patients making an attempt at smoking cessation during lung cancer workup | Binary outcome (Attempt: yes, no) | 6 weeks after baseline | |
Secondary | Motivation to quit smoking | Numeric rating scale (0-10) with higher score indicating stronger motivation | 6 weeks, 3, 6, and 12 months after baseline | |
Secondary | Proportion of patients who are not smoking at the time of measurement | Binary outcome (Currently smoking: yes, no) | 6 weeks, 3, 6, and 12 months after baseline | |
Secondary | Quality of life as measured by the 36 item Short Form Survey (SF-36) | SF-36, two components: Mental and Physical. Each components scale has a total score range from 5 (worst health) to 80 (best health) | 6 weeks, 3, 6, and 12 months after baseline | |
Secondary | Psychosocial consequences of lung cancer workup | Consequences of Screening - Lung Cancer Questionnaire (adapted to the lung cancer workup setting). Items in Part 1 of the questionnaire focuses on experiences during the cancer workup with a total score range from 0 (low level of psychosocial consequences) to 72 (high level of psychosocial consequences). Items in Part 2 of the questionnaire focuses on experiences after the cancer workup with a total score range from 0 (low level of psychosocial consequences) to 22 (high level of psychosocial consequences). | 6 weeks after baseline | |
Secondary | Hospitals' number of referrals to municipality-based smoking cessation programmes | Change from one year before to one year after intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02060877 -
Distress and Quality of Life During the Diagnostic Phase of a Suspected Serious Lung Disease
|
N/A |